GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 90 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $30,079 | -10.2% | 17,488 | +1.9% | 0.00% | – |
Q2 2023 | $33,477 | -46.0% | 17,168 | +14.1% | 0.00% | – |
Q1 2022 | $62,000 | -74.5% | 15,041 | -20.5% | 0.00% | – |
Q4 2021 | $243,000 | +153.1% | 18,912 | +80.5% | 0.00% | – |
Q2 2021 | $96,000 | -4.0% | 10,476 | -5.8% | 0.00% | – |
Q4 2019 | $100,000 | – | 11,121 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 3,102,929 | $18,059,047,000 | 4.95% |
Svennilson Peter | 3,102,934 | $18,059,000 | 2.29% |
Casdin Capital, LLC | 2,270,000 | $13,211,000 | 1.40% |
FRAZIER MANAGEMENT LLC | 2,061,758 | $11,999,000 | 1.36% |
Redmile Group, LLC | 3,068,194 | $17,857,000 | 0.50% |
Alphabet Inc. | 929,022 | $5,407,000 | 0.36% |
Bleichroeder LP | 169,039 | $984,000 | 0.26% |
Leap Investments LP | 14,400 | $84,000 | 0.12% |
DAFNA Capital Management LLC | 50,000 | $291,000 | 0.12% |
Blackstone Inc. | 2,567,445 | $14,943,000 | 0.11% |